Health

Rachel Feltman of Scientific American’s “Science Quickly” podcast visits MIT.nano to learn more about MIT’s “clean laboratory facility that is critical to nanoscale research, from microelectronics to medical nanotechnology.” Prof. Vladimir Bulović, director of MIT.nano, explains: “Maybe a fifth of all of M.I.T.’s research depends on this facility…from microelectronics to nanotechnology for medicine to different ways of rethinking what will [the] next quantum computation look like. Any of these are really important elements of what we need to discover, but we need all of them to be explored at the nanoscale to get that ultimate performance.” 

Prof. Jeffrey Harris speaks with Newsweek reporter Jasmine Laws about how a recession could impact Medicare. "A recession could impact many critical decisions of federal lawmakers, private insurers, healthcare providers, and patients,” says Harris. “The U.S. Congress may decide to let stand the Medicare physician payment cut that became effective on January 1 of this year. Reduced physician payments under conventional Medicare may cause doctors, hospitals and other providers to shift their resources toward the care of younger, commercially insured patients."

Writing for The Boston Globe, Prof. Pierre Azoulay and Prof. Jeffrey Flier of Harvard Medical School make the case that any reforms at the NIH “should be grounded in evidence rather than tradition, avoiding the influence of special interests or political considerations.” They add that this approach “is an acknowledgement of NIH’s accomplishments and a charge to adapt it to the new realities of 21st-century science. The overarching goal must be to secure and enhance the decades-long role of the United States at the forefront of biomedical research, an outcome that the public both wants and deserves.”

MIT has multiple projects represented in this year’s STAT Madness, a bracket-style competition “highlighting important scientific advances emerging from labs at the nation’s universities, medical schools, and other U.S. research institutions and companies,” reports STAT staff.

Evan Ehrenberg PhD '16 co-founded Waterlily, a company that “uses artificial intelligence to predict a family’s future long-term care needs and costs” with the right care and financial planning, reports Mary Ann Azevedo for TechCrunch. “Ehrenberg — who had previously founded and sold Clara Health — helped with early research and was struck by the industry’s response,” writes Azevedo. “Curious, he tested the platform and was shocked by his long-term care predictions — so much so that he changed his diet, hired a personal trainer, and updated his financial plans.” 

In an article for The New York Times, Prof. Pranav Rajpurkar of Harvard and Prof. Eric J. Topol of Scripps highlight a recent study by MIT researchers that examined “how radiologists diagnose potential diseases from chest X-rays.” They write that the study’s findings “broadly indicate that right now, simply giving physicians A.I. tools and expecting automatic improvements doesn’t work. Physicians aren’t completely comfortable with A.I. and still doubt its utility, even if it could demonstrably improve patient care.”

WCVB-TV's Chronicle spotlights Prof. Linda Griffith, “a forerunner in the field of biological engineering,” for her research investigating endometriosis and breaking the stigma around menstruation. Griffith founded the MIT Center for Gynepathology Research in 2009 and “one of their objectives is to help develop ways of staging endometriosis, similar to how cancer is characterized.” Griffith notes that by focusing on menstruation and making it a science, “I think we will really change the game for women.

Prof. Giovanni Traverso speaks with GBH’s “All Things Considered” host Arun Rath about his work developing new approaches to weight loss treatments that don’t involve surgery or pharmaceuticals. “Our team does a lot of work on ingestible systems, ingestible capsules that can do many things,” says Traverso. “You know, we recognize that we live now in a world where we have really incredible therapies that are very effective for the treatment of diabetes and obesity. But we also recognize that they’re not for everybody. There are people who have side effects, people who can’t take them, so these are certainly alternatives, or potentially synergistic interventions, that could work together either with those drugs or, as I was mentioning, for folks that have side effects from the drugs.”

Researchers at MIT have developed a new type of dynamic gastric balloon that inflates on demand and could be used to help patients feel more full before meals, reports Margherita Bassi for Gizmodo. The engineers have “designed a potential future alternative for patients who, for any number of reasons, cannot treat obesity through medications or invasive surgeries such as gastric bypass surgery or stapling,” writes Bassi. 

Boston Business Journal reporter Hannah Green spotlights the MIT Health and Life Sciences Collaborative, a new effort designed to connect researchers, medical professionals, and industry leaders in a shared mission to address some of the most pressing health challenges of our time. Green notes that the collaborative aims to “spur high-impact discoveries and health solutions through interdisciplinary projects across engineering, science, AI, economics, business, policy, design, and the humanities.” 

Professor Giovanni Traverso and his colleagues have developed a new gastric balloon that can be inflated and deflated to mimic feeling full. Unlike traditional gastric balloons, which are one size, the new version is “connected to an external control device that can be attached to the skin and contains a pump that inflates and deflates the balloon when needed,” writes Ernie Mundell for HealthDay. 

MIT researchers have developed a gastric balloon that can inflate before eating and contract afterwards in an effort to ensure the body does not grow accustomed to the balloon, reports Nicola Davis for The Guardian. “What we try to do here is, in essence, simulate the mechanical effects of having a meal,” explains Prof. Giovanni Traverso. “What we want to avoid is getting used to that balloon." 

Inspired by his daily walks, Prof. Elfatih Eltahir and his colleagues have developed a new way to measure how climate change is likely to impact the number of days when it is comfortable to be outdoors, reports Maddie Browning for WBUR. “I find people walking, jogging, cycling and enjoying the outdoors,” says Eltahir. “That's what motivated me to start looking at how climate change could really constrain some of those activities.”

Researchers at MIT have found that “more than 98% of prisons in the United States experienced at least ten days that were hotter than every previous summer, with the worst of the heat-exposed prisons concentrated in the Southwest,” reports Minnah Arshad for USA Today. s

MIT researchers developed a new method to model how climate change will impact the number of “outdoor days” and found that Southern states in the U.S. will lose a significant number of outdoor days, reports Kristin Toussaint for Fast Company. Prof. Elfatih Eltahir explains that the concept of outdoor days is, “an attempt for me to bring the issue of climate change home. When someone tells you global temperatures are going to increase by 3 degrees, that’s one thing. If someone tells you that your outdoor days will be dropping by 20% or 30%, that’s another thing.”